Results 271 to 280 of about 2,362,461 (350)

Evaluation of oral immunotherapy in hazelnut allergy: Pediatric experience in Toulouse. [PDF]

Allergy
Casanovas N, Gruzelle V, Broue-Chabbert A, Pontcharraud R, Kamphuis J, Martin-Blondel A, Guilleminault L, Michelet M.   +7 more
europepmc   +1 more source

Oral Immunotherapy Should Play a Key Role in Preschool Food Allergy Management. [PDF]

Clin Exp Allergy
Soller L, Chan ES, Cameron SB, Abrams EM, Kapur S, Carr SN, Vander Leek TK.   +6 more
europepmc   +1 more source

Impact of Dermatology Consult on Inpatient and Acute Care Management of Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
Natalie Baker, Baraa Hijaz, Allison Holt, Joseph Ebriani, Bethany J. Brumbaugh, Michael Stephens, John Trinidad, Arash Mostaghimi, Daniela Kroshinsky, Steven T. Chen   +9 more
wiley   +1 more source

Peanut challenges prior to oral immunotherapy demonstrate high tolerance rates in selected patients. [PDF]

J Allergy Clin Immunol Glob
Gard CN, Sanders GM, Slack IF, Schuler CF, Freigeh GE, O'Shea KM.   +5 more
europepmc   +1 more source

Omalizumab and Oral Immunotherapy in IgE-Mediated Food Allergy in Children: A Systematic Review and a Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
Buono EV, Giannì G, Scavone S, Esposito S, Caffarelli C.   +4 more
europepmc   +1 more source

Oral immunotherapy improves the quality of life of adults with food allergy. [PDF]

Allergy Asthma Clin Immunol
Epstein-Rigbi N, Levy MB, Nachshon L, Koren Y, Goldberg MR, Elizur A.   +5 more
europepmc   +1 more source

Development and acceptability of a decision-aid for food allergy oral immunotherapy in children. [PDF]

Allergy
Anagnostou A, Abrams EM, Carver M, Chan ES, Eftekhari S, Greiwe J, Jaffee H, Lieberman JA, Mack DP, Mustafa SS, Shaker MS, Stukus D, Wang J, Greenhawt M.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Wheat oral immunotherapy

Current Opinion in Allergy & Clinical Immunology, 2021
Purpose of review The prevalence of food allergy is increasing on a global scale, and therefore increased attention is being paid to specific food allergy epidemiology and management.
S. Leeds, Elise G. Liu, A. Nowak‐Wegrzyn   +2 more
semanticscholar   +3 more sources

Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age.

NEJM Evidence, 2023
Oral Immunotherapy for Peanut Allergy in ChildrenThis trial enrolled children 1 to
G. du Toit, K. Brown, A. Vereda, A. Irani, S. Tilles, Anoshie Ratnayake, S. Jones, B. Vickery   +7 more
semanticscholar   +1 more source

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.

The Lancet Child & Adolescent Health, 2022
BACKGROUND Oral immunotherapy is effective at inducing desensitisation to allergens and induces sustained unresponsiveness (ie, clinical remission) in a subset of patients, but causes frequent reactions.
P. Loke, F. Orsini, Adriana C Lozinsky, M. Gold, M. O'Sullivan, P. Quinn, M. Lloyd, S. Ashley, Sigrid Pitkin, C. Axelrad, J. Metcalfe, E. Su, D. Tey, M. Robinson, K. Allen, S. Prescott, A. D. Galvin, M. Tang   +17 more
semanticscholar   +1 more source